Pure Global

Febrile antigen kit - India CDSCO Medical Device Registration

Febrile antigen kit is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2018/000005_ff2634cdaadf693da88c0097ee6bd035_02c719c815292a3a229b8f490adb2473. This device is marketed under the brand name Pathozyme® Ovarian Cancer Antigen Ag 125 ELISA. The license holder is Omega DX (Asia) Private Limited, and it is classified as Device Class Class C. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class C
Febrile antigen kit
UID: IMP/IVD/2018/000005_ff2634cdaadf693da88c0097ee6bd035_02c719c815292a3a229b8f490adb2473

Brand Name

Pathozyme® Ovarian Cancer Antigen Ag 125 ELISA

Device Class

Class C

Approving Authority

CDSCO

Product Information

Micropath® SAL H-D is an in-vitro diagnostic kit used for detection of antibodies to various bacterial pathogens by the slide or tube agglutination method

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing